If the results show improved maternal and fetal/neonatal outcomes using metformin, then physicians treating women with type 2 diabetes in pregnancy will choose to use metformin with insulin as a new standard of care, to reduce serious perinatal morbidity. The gene discussed is INS; the disease is type 2 diabetes mellitus.